Vicki Marie Haines
Nurse Practitioner • Pasco, WA
9221 Sandifur Pkwy Ste A
Pasco, WA 993019241
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 14, 2011; this date does not establish years in practice.
-
Published CMS data list 8,784 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J7345 — Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg: 4,600 service units.
- 17003 — Destruction of precancer skin growth, 2-14 growths: 1,825 service units.
- 99213 — Established patient outpatient office visit: 633 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 23 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,006 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Triamcinolone Acetonide — 284 prescription fills, including refills.
- Methotrexate (Methotrexate Sodium) — 121 prescription fills, including refills.
- Nystatin — 94 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Washington (2024, 893 clinicians with data). Median for this group: 234. Middle half: 84 to 502.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 13,663 in 2020 to 8,784 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
9221 Sandifur Pkwy Ste A
Pasco, WA 993019241
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Walla Walla, WA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Atomic Dermatology Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2010
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
806 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $227,588 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $157,311 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,176 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,854,535 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $19,168.96 across 203 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $14,130.00 across 17 records.
- Food and Beverage: $2,929.67 across 179 records.
- Honoraria: $1,140.00 across 2 records.
Reporting-company totals (3 largest of 19)
- Eli Lilly and Company: $4,952.41 across 12 records.
- Regeneron Pharmaceuticals, Inc.: $3,130.00 across 10 records.
- Galderma Laboratories, L.P.: $2,975.68 across 12 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
16 years (graduated 2010)
CMS Doctors and Clinicians data list 2010 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Vicki Haines has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Vicki Haines as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Pasco and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Washington (2024, 893 clinicians with data). Median for this group: 234. Middle half: 84 to 502.
Too few clinicians listed under Nurse Practitioner in Pasco have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Nurse Practitioner in Washington (2024, 893 clinicians with data). Median for this group: $18,362. Middle half: $7,179 to $35,594.
Too few clinicians listed under Nurse Practitioner in Pasco have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Nurse Practitioner in Washington (2024, 893 clinicians with data). Median for this group: $13,803. Middle half: $5,221 to $25,979.
Too few clinicians listed under Nurse Practitioner in Pasco have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Washington (2024, 1,099 clinicians with data). Median for this group: 277. Middle half: 74 to 877.
Too few clinicians listed under Nurse Practitioner in Pasco have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in Washington (2024, 1,099 clinicians with data). Median for this group: $11,694. Middle half: $1,114 to $110,470.
Too few clinicians listed under Nurse Practitioner in Pasco have Medicare Part D data for 2024 to compare.
12 active clinicians are listed under Nurse Practitioner with a practice address in Pasco, WA (2,310 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Pasco
0% of these 12 clinicians have the CMS telehealth indicator.
50% of these 12 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 36% from 13,663 in 2020 to 8,784 in 2024.
- 2020: 13,663
- 2021: 11,333
- 2022: 9,191
- 2023: 12,185
- 2024: 8,784
-
Medicare-allowed amount
Medicare-allowed amount decreased 52% from $478,957 in 2020 to $227,588 in 2024.
- 2020: $478,957
- 2021: $1,559,282
- 2022: $2,093,990
- 2023: $206,222
- 2024: $227,588
-
Paid by Medicare
Paid by Medicare decreased 56% from $359,683 in 2020 to $157,311 in 2024.
- 2020: $359,683
- 2021: $1,225,150
- 2022: $1,648,997
- 2023: $143,798
- 2024: $157,311
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 45% from 693 in 2020 to 1,006 in 2024.
- 2020: 693
- 2021: 935
- 2022: 715
- 2023: 713
- 2024: 1,006
-
30-day fills
30-day fills increased 49% from 792 in 2020 to 1,176 in 2024.
- 2020: 792
- 2021: 1,052
- 2022: 851
- 2023: 857
- 2024: 1,176
-
Part D drug cost
Part D drug cost increased 115% from $864,036 in 2020 to $1,854,535 in 2024.
- 2020: $864,036
- 2021: $897,441
- 2022: $1,418,250
- 2023: $1,447,715
- 2024: $1,854,535
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 119% from $8,768.03 in 2021 to $19,168.96 in 2025.
- 2021: $8,768.03
- 2022: $12,604.50
- 2023: $10,590.35
- 2024: $5,679.59
- 2025: $19,168.96
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 203 records totaling $19,168.96.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $1,373.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $1,350.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,200.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,200.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $1,125.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $950.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $950.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $861.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $760.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $750.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $615.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $615.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $600.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Honoraria
In-kind items and services
|
— | General | $570.00 |
| MAYNE PHARMA COMMERCIAL LLC |
Honoraria
In-kind items and services
|
— | General | $570.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $450.00 |
| LEO Pharma Inc. |
Consulting Fee
Cash or cash equivalent
|
ADBRY | General | $450.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $431.00 |
| LEO Pharma Inc. |
Consulting Fee
Cash or cash equivalent
|
ADBRY | General | $400.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $300.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $118.41 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $112.95 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $108.32 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $99.99 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J7345
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
|
4,600 | 20 | $2.00 | $1.67 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
1,825 | 291 | $12.00 | $5.78 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
633 | 533 | $150.00 | $77.52 |
|
17000
Destruction of precancer skin growth, 1 growth
|
460 | 358 | $138.56 | $43.55 |
|
17110
Destruction of skin growth, 1-14 growths
|
351 | 312 | $225.00 | $94.21 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
172 | 137 | $90.00 | $48.39 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
152 | 99 | $305.00 | $144.34 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
74 | 74 | $150.00 | $61.88 |
|
11642
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
|
53 | 39 | $550.00 | $188.15 |
|
11102
Biopsy of related skin growth, first growth
|
49 | 49 | $250.00 | $71.76 |
|
11602
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
49 | 30 | $500.00 | $161.37 |
|
17111
Destruction of skin growth, 15 or more growths
|
49 | 46 | $270.00 | $111.59 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
47 | 41 | $215.00 | $109.46 |
|
11622
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
|
46 | 22 | $520.00 | $172.91 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
43 | 43 | $215.00 | $95.09 |
|
11200
Removal of skin tag, 1-15 skin tags
|
42 | 38 | $180.00 | $54.10 |
|
12031
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less
|
28 | 26 | $538.08 | $208.32 |
|
G0168
Wound closure utilizing tissue adhesive(s) only
|
26 | 26 | $250.99 | $103.57 |
|
96574
Application of light with debridement to destroy precancer skin growth
|
23 | 20 | $570.89 | $240.53 |
|
12051
Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less
|
17 | 17 | $525.00 | $225.95 |
|
11641
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
|
16 | 12 | $480.00 | $146.85 |
|
11603
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
|
15 | 12 | $575.00 | $167.05 |
|
11643
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm
|
14 | 13 | $650.00 | $233.37 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone Acetonide | 284 | 9,282 | $3,788.67 | 155 |
| Methotrexate | Methotrexate Sodium | 121 | 4,666 | $1,273.91 | 37 |
| Nystatin | Nystatin | 94 | 2,410 | $1,399.01 | 44 |
| Clobetasol Propionate | Clobetasol Propionate | 84 | 2,562 | $3,512.99 | 37 |
| Dupixent Pen | Dupilumab | 71 | 1,974 | $297,841.70 | 11 |
| Fluconazole | Fluconazole | 38 | 1,250 | $671.10 | 33 |
| Cosentyx Unoready Pen | Secukinumab | 36 | 1,022 | $382,429.94 | — |
| Humira(Cf) Pen | Adalimumab | 32 | 896 | $309,083.99 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 829 | $730.01 | 23 |
| Tacrolimus | Tacrolimus | 29 | 730 | $3,591.22 | 16 |
| Skyrizi Pen | Risankizumab-Rzaa | 28 | 2,240 | $620,251.25 | — |
| Mupirocin | Mupirocin | 22 | 542 | $135.81 | — |
| Cosentyx Sensoready (2 Pens) | Secukinumab | 22 | 644 | $180,076.96 | — |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 18 | 732 | $713.97 | — |
| Clindamycin Phosphate | Clindamycin Phosphate | 17 | 495 | $449.82 | 12 |
| Acyclovir | Acyclovir | 16 | 101 | $118.58 | 15 |
| Terbinafine Hcl | Terbinafine Hcl | 16 | 610 | $144.42 | 13 |
| Prednisone | Prednisone | 13 | 135 | $54.59 | — |
| Spironolactone | Spironolactone | 12 | 644 | $32.04 | — |
| Imiquimod | Imiquimod | 11 | 270 | $393.13 | — |
| Dupixent Syringe | Dupilumab | 11 | 308 | $47,841.94 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-01-09NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20110419000185
WA
5496939381
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Atomic Dermatology Llc
9221 Sandifur Pkwy, Pasco, WA 993019241
Phone: 5092337546
Atomic Dermatology Llc
9221 Sandifur Pkwy A, Pasco, WA 993019241
Secondary Practice Locations
105 S 3rd Ave
Walla Walla, WA 993622848
Phone: 5092402554
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 9221 SANDIFUR PKWY STE A, PASCO, WA 993019241 (Tel: 5092337546)
Registered at 9221 SANDIFUR PKWY STE A, PASCO, WA 993019241 (Tel: 5092337546)
NPI status registered as active in NPPES database
Registered at 112 COLUMBIA POINT DR, SUITE 101, RICHLAND, WA 993524390 (Tel: 5099423180)
Registered at 3900 S ZINTEL WAY, KENNEWICK, WA 993375092 (Tel: 5099423627)
Recorded as VICKI HAINES
Nurse Practitioner (license number reported to NPPES: WA AP60211812)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Pasco
- Rebekah Pierson, ARNP
- Carrie Reed, RN, CNM-BC, FNP-BC
- Gary Thomas, NP
- Gesamae Mcelvain, NP
- Andrea Munder, ARNP
- Marybella Dodson, NURSE PRACTITIONER
Mailing Address
9221 Sandifur Pkwy Ste A
Pasco, WA 993019241
Phone: 5092337546